In silico-based Discovery of New Potential Drugs Targeting Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein
The SARS-CoV-2-induced novel coronavirus disease has become a global pandemic. As the latest coronavirus variants are even more infectious and deadly, its treatment is very difficult. Currently used drugs such as remdesivir, saquinavir, and chloroquine have several drawbacks. Recent studies have rep...
Saved in:
| Main Authors: | Hayam Abdelkader, Mahmoud Rifaat, Mohammed Baghdadi, Nariman Sindi, Radwa Rifaat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2021-10-01
|
| Series: | Dr. Sulaiman Al Habib Medical Journal |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.2991/dsahmj.k.211103.001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
by: Naveen Vankadari, et al.
Published: (2020-01-01) -
Lopinavir and Ritonavir have High Affinity Toward the SARS-CoV-2 S-protein Receptor-binding Domain Sequenced in Brazil
by: Aline Diogo Marinho, et al.
Published: (2025-01-01) -
Antibodies and vaccines against Middle East respiratory syndrome coronavirus
by: Jiuyang Xu, et al.
Published: (2019-01-01) -
Anticoronavirus activity of C60 fullerene: in silico and in vitro screening
by: Василь Гурмач, et al.
Published: (2025-08-01) -
Designing an optimized theta-defensin peptide for HIV therapy using in-silico approaches
by: Mosalanejad Zahra, et al.
Published: (2025-03-01)